Welcome to the detailed analysis for opdivo.com. This domain is officially recognized as OPDIVO® & OPDIVO Qvantig®. According to their official web presence, their primary focus is: "Whether you're a new or continuing OPDIVO® or OPDIVO Qvantig® patient, find resources that can support you through a cancer diagnosis and during treatment. Access helpful resources and find assistance here. Please see Indication and Important Safety Information.".
"Discover faster* administration with OPDIVO Qvantig® (nivolumab + hyaluronidase-nvhy), an immunotherapy treatment given by injection that is FDA approved to treat most cancer types approved for OPDIVO® (nivolumab).†"
"*A 3-5 minute injection time of OPDIVO Qvantig compared to a 30-minute infusion time of OPDIVO. This does not account for all aspects of treatment. Does not include observation time. Actual clinic time may vary."
"†OPDIVO Qvantig is not indicated for co-administration with YERVOY® (ipilimumab)."
"You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO"
By comparing opdivo.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to opdivo.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of September 28, 2026, opdivo.com holds an estimated domain authority score of 77/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to opdivo.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for opdivo.com: